FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a medicinal agent for chronic wound therapy. Drug for chronic wound therapy is characterized by that it contains bacterial lipopolysaccharide, trehalose dibehennate, a water-soluble cellulose derivative, a polyatomic alcohol, preserving agents and purified water taken in a certain ratio.
EFFECT: agent described above has high efficacy in therapy of chronic wounds and is able to target simultaneously two receptors of the innate immune response, namely TLR4 and Mincle (CLEC4E) receptors.
7 cl, 2 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STIMULATING SKIN AND MUCOUS LINING DEFECT REPAIR AND MEDICINAL AGENT FOR REALISING SAID METHOD | 2011 |
|
RU2447082C1 |
| MEDICINAL PREPARATION IN FORM OF SOL FOR TREATING A DISEASE AND/OR CONDITION CHARACTERIZED BY VIOLATION OF SKIN INTEGRITY, AND A METHOD FOR PREPARING IT | 2019 |
|
RU2742752C1 |
| CHAPERONIN 10 MODULATION OF TOLL-LIKE RECEPTOR INDUCIBLE CYTOKINE AND CHEMOKINE SECRETION | 2005 |
|
RU2446817C2 |
| MULTICOMPONENT VACCINE FOR IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF DISEASES CAUSED BY OPPORTUNISTIC PATHOGENS | 2022 |
|
RU2786222C1 |
| HOP EXTRACT | 2007 |
|
RU2344167C2 |
| COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
| BROAD-SPECTRUM M2 PROTEIN ECTODOMAIN AVIAN INFLUENZA TYPE A VACCINE | 2014 |
|
RU2571944C1 |
| IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
| INTRODUCTION OF ERYTHORANE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR ORTHOMYXOVIRAL INFECTIONS TREATMENT | 2013 |
|
RU2636622C2 |
| APPLICATION OF BACTERIAL GHOSTS FOR MEDIATED STIMULATION OF INNATE IMMUNITY | 2011 |
|
RU2564110C2 |
